Complement activation as a cause of transient hypotension during plasmapheresis

被引:16
作者
Shiga, Y [1 ]
Fujihara, K [1 ]
Onodera, H [1 ]
Nagata, T [1 ]
Itoyama, Y [1 ]
机构
[1] Tohoku Univ, Sch Med, Dept Neurol, Aoba Ku, Sendai, Miyagi 9808574, Japan
关键词
plasmapheresis; immunoadsorption plasmapheresis; double filtration plasmapheresis; adverse effect; hypotension; activated complement;
D O I
10.1046/j.1525-1594.1998.06170.x
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Hypotension is one of the most common adverse effect of plasmapheresis (PP) and often is attributed to hypovolemia due to extracorporeal circulation and the vasovagal reflex. Complements are activated during PP, and the activated complements are strong anaphylatoxins and potent vasodilators. Therefore, we studied the relationship between the transient hypotension and the plasma levels of activated complements during and after PP in 8 sessions of 7 patients using the Plasmafro OF-08 as a plasma separator. Five of the patients underwent immunoadsorption PP using the IM-TR 350 or IM-PH 350 as the adsorption column. The other underwent double filtration PP using the Evaflux 4A as a second filter. In 4 of 8 sessions, patients experienced transient hypotension with significantly elevated plasma levels of activated complements C3a and C5a. In contrast, patients without hypotension showed no increases in C3a and C5a values during PP. In this report, we emphasize the critical role of activated complements for hypotension during PP.
引用
收藏
页码:1067 / 1069
页数:3
相关论文
共 10 条
[1]  
ALARABI AA, 1993, ARTIF ORGANS, V17, P782
[2]  
CHIDA K, 1996, CLIN NEUROL TOKYO, V36, P551
[3]   COMPLEMENT PEPTIDES C3A-INDUCED AND C5A-INDUCED MEDIATOR RELEASE FROM DISSOCIATED HUMAN SKIN MAST-CELLS [J].
ELLATI, SG ;
DAHINDEN, CA ;
CHURCH, MK .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1994, 102 (05) :803-806
[4]   TREATMENT OF MYASTHENIA-GRAVIS BY IMMUNOADSORPTION OF PLASMA [J].
GROB, D ;
SIMPSON, D ;
MITSUMOTO, H ;
HOCH, B ;
MOKHTARIAN, F ;
BENDER, A ;
GREENBERG, M ;
KOO, A ;
NAKAYAMA, S .
NEUROLOGY, 1995, 45 (02) :338-344
[5]  
HETLAND G, 1991, CLIN EXP IMMUNOL, V84, P535
[6]   HEMODIALYZER PERFORMANCE - BIOLOGICAL INDEXES [J].
HOLMES, CJ .
ARTIFICIAL ORGANS, 1995, 19 (11) :1126-1135
[7]   IMMUNOMODULATION - BIOENGINEERING ASPECTS [J].
MALCHESKY, PS .
ARTIFICIAL ORGANS, 1986, 10 (02) :128-134
[8]   THE ANAPHYLATOXINS C3A AND C5A ARE VASODILATORS IN THE CANINE CORONARY VASCULATURE INVITRO AND INVIVO [J].
SCHUMACHER, WA ;
FANTONE, JC ;
KUNKEL, SE ;
WEBB, RC ;
LUCCHESI, BR .
AGENTS AND ACTIONS, 1991, 34 (3-4) :345-349
[9]  
Tagawa Y, 1997, Ther Apher, V1, P336, DOI 10.1111/j.1744-9987.1997.tb00050.x
[10]   RADIOIMMUNOASSAY FOR ANAPHYLATOXINS - A SENSITIVE METHOD FOR DETERMINING COMPLEMENT ACTIVATION PRODUCTS IN BIOLOGICAL-FLUIDS [J].
WAGNER, JL ;
HUGLI, TE .
ANALYTICAL BIOCHEMISTRY, 1984, 136 (01) :75-88